JPRN-UMIN000019512招募中未知
Efficacy of Humira(Adalimumab) in patients with moderate to severe ulcerative colitis (KyuSyu IBD project) - HAWKS study
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients who Contraindicate for adalimumab. 2.Patients who can not provide informed consent. 3.Patients who have malignancy 4.Patients who judged to be disqualified by the physician
研究者
相似试验
已完成
3 期
Efficacy of MabAsia (Adalimumab) in Rheumatoid ArthritisRheumatoid Arthritis.Seropositive Rheumatoid ArthritisIRCT2014090319025N1Vice Chancellor for research, Tehran University of Medical Sciences105
进行中（未招募）
不适用
EFFICACY AND SAFETY OF ADALIMUMAB (HUMIRA®) IN PATIENTS WITH PERIPHERAL SPONDYLOARTHRITIS WITHOUT ANKYLOSING SPONDYLITIS OR PSORIATIC ARTHRITISPERIPHERAL SPONDYLOARTHRITIS WITHOUT ANKYLOSING SPONDYLITIS OR PSORIATIC ARTHRITISMedDRA version: 9.1Level: LLTClassification code 10051265Term: SpondyloarthropathyEUCTR2008-006885-27-NLClinical Immunology and Rheumatology
招募中
不适用
The efficacy of anamorelin for the patients with metastatic urothelial carcinoma treated by systemic chemotherapy.urothelial carcinomaJPRN-jRCTs041210041aiki Taku40
进行中（未招募）
1 期
An open label study of humira (adalimumab)in the treatment of patients with severe psoriasis - Open label study of humira in patients with severe psoriasis version 1PsoriasisMedDRA version: 8.1Level: LLTClassification code 10037153Term: PsoriasisEUCTR2006-004260-31-GBHL NHS Trust
尚未招募
2 期
Efficacy and safety of adalimumab in patients with peripheral spondyloarthritis without ankylosing spondylitis or psoriatic arthritis.NL-OMON32839Academisch Medisch Centrum40